4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-26-000006
President and CEO gave up 6,155 shares (to pay taxes)
- President and CEO acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-12 | Grant or award : show line 1 in the form | +4,800 | 862,826 | D | ||
| 2026-02-12 | Grant or award : show line 2 in the form | +15,200 | 878,026 | D | ||
| 2026-02-12 | Shares withheld for taxes : show line 3 in the form | −6,155 | $14.25 | $87,709 | 871,871 | D |
Loading xslF345X05/form4.xml…